» Articles » PMID: 36561297

Analysis of Co-expression Gene Network Associated with Intracranial Aneurysm and Type 2 Diabetes Mellitus

Overview
Journal Front Neurol
Specialty Neurology
Date 2022 Dec 23
PMID 36561297
Authors
Affiliations
Soon will be listed here.
Abstract

To screen for common target genes in intracranial aneurysms (IA) and type 2 diabetes mellitus (T2DM), construct a common transcriptional regulatory network to predict clusters of candidate genes involved in the pathogenesis of T2DM and IA, and identify the common neurovascular markers and pathways in T2DM causing IA. Microarray datasets (GSE55650, GSE25462, GSE26969, GSE75436, and GSE13353) from the GEO database were analyzed in this research. Screening of the IA and the T2DM datasets yielded a total of 126 DEGs, among which 78 were upregulated and 138 were downregulated. Functional enrichment analysis revealed that these DEGs were enriched for a total of 68 GO pathways, including extracellular matrix composition, coagulation regulation, hemostasis regulation, and collagen fiber composition pathways. We also constructed transcriptional regulatory networks, and identified key transcription factors involved in both the conditions. Univariate logistic regression analysis showed that ARNTL2 and STAT1 were significantly associated with the development of T2DM and IA, acting as the common neurovascular markers for both the diseases. In cellular experiments, hyperglycemic microenvironments exhibited upregulated STAT1 expression. STAT1 may be involved in the pathogenesis of IA in T2DM patients. Being the common neurovascular markers, STAT1 may acts as novel therapeutic targets for the treatment of IA and T2DM.

Citing Articles

Comprehensive analysis of mitochondrial dysfunction and necroptosis in intracranial aneurysms from the perspective of predictive, preventative, and personalized  medicine.

Chen B, Xie K, Zhang J, Yang L, Zhou H, Zhang L Apoptosis. 2023; 28(9-10):1452-1468.

PMID: 37410216 PMC: 10425526. DOI: 10.1007/s10495-023-01865-x.

References
1.
Vargas-Hernandez A, Mace E, Zimmerman O, Zerbe C, Freeman A, Rosenzweig S . Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations. J Allergy Clin Immunol. 2017; 141(6):2142-2155.e5. PMC: 5924437. DOI: 10.1016/j.jaci.2017.08.040. View

2.
Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z . clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb). 2021; 2(3):100141. PMC: 8454663. DOI: 10.1016/j.xinn.2021.100141. View

3.
Ceriello A, Giacomello R, Stel G, Motz E, Taboga C, Tonutti L . Hyperglycemia-induced thrombin formation in diabetes. The possible role of oxidative stress. Diabetes. 1995; 44(8):924-8. DOI: 10.2337/diab.44.8.924. View

4.
You W, Hong Y, He H, Huang X, Tao W, Liang X . TGF-β mediates aortic smooth muscle cell senescence in Marfan syndrome. Aging (Albany NY). 2019; 11(11):3574-3584. PMC: 6594817. DOI: 10.18632/aging.101998. View

5.
Starke R, Chalouhi N, Ali M, Jabbour P, Tjoumakaris S, Gonzalez L . The role of oxidative stress in cerebral aneurysm formation and rupture. Curr Neurovasc Res. 2013; 10(3):247-55. PMC: 3845363. DOI: 10.2174/15672026113109990003. View